StrokeViewer Perfusion vs HALO

Direct competitors — feature-level head-to-head below. Comparability 90/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

StrokeViewer Perfusion

by NICo-Lab B.V.

HALO

by Nico.Lab B.V.

AI Verdict

These two tools are direct competitors, both developed by Nico.Lab B.V. for acute stroke diagnosis and management. While both detect large vessel occlusions and intracerebral hemorrhage, StrokeViewer Perfusion specializes in quantitative CT perfusion analysis for detailed brain tissue information, including core and penumbra volumes. HALO, on the other hand, focuses on rapid detection and triage, facilitating the evaluation of brain vasculature on CT angiograms and providing broader clinical support.

Choose StrokeViewer Perfusion if…

Choose StrokeViewer Perfusion if your clinical workflow requires detailed, quantitative analysis of brain tissue viability from CT perfusion scans. This tool is ideal for precisely quantifying core and penumbra volumes, providing comprehensive perfusion maps, and assessing collateral circulation to guide advanced reperfusion therapies.

View StrokeViewer Perfusion →

Choose HALO if…

Choose HALO if your primary need is rapid, AI-powered detection of critical findings like Large Vessel Occlusions and Intracerebral Hemorrhage for immediate stroke triage and specialist notification. HALO is best suited for quickly identifying acute stroke patients requiring urgent intervention, streamlining the initial diagnostic workflow and accelerating time-to-treatment decisions.

View HALO →

When choosing between StrokeViewer Perfusion and HALO, both developed by Nico.Lab B.V., physicians should consider their primary need in acute stroke management. StrokeViewer Perfusion excels in comprehensive quantitative analysis of CT perfusion scans, providing detailed brain tissue information such as TMax, CBF, and CBV maps, along with core and penumbra volume quantification. This tool is ideal for physicians who require in-depth physiological data to guide treatment decisions, particularly in cases where detailed tissue viability assessment is critical. Its ability to assess collateral circulation and perform ASPECTS scoring further supports nuanced diagnostic evaluations.

In contrast, HALO focuses on rapid detection and notification of critical findings: Large Vessel Occlusions (LVOs) and Intracerebral Hemorrhage (ICH). While both tools detect LVOs and hemorrhage, HALO’s core strength lies in its streamlined, cloud-based workflow designed for immediate alerts to specialists, facilitating quicker triage and intervention. The key practical difference is that StrokeViewer Perfusion offers a deeper dive into perfusion metrics, whereas HALO prioritizes speed and direct communication of urgent pathologies. Physicians needing extensive quantitative perfusion data for complex decision-making may lean towards StrokeViewer Perfusion. Conversely, those prioritizing rapid, automated alerts for critical stroke indicators to expedite patient management, especially in high-volume emergency settings, would find HALO more aligned with their workflow.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	StrokeViewer Perfusion	HALO
Pricing	Contact for pricing	Not disclosed
Deployment	Cloud-based; can be installed as a Docker container on standard computers or virtual platforms.	Cloud-based (Google Cloud Platform)
FDA Status	1 AI-estimated	1 AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Tie

Both tools emphasize ease of integration and timely notifications. HALO explicitly mentions remote review via a compatible DICOM web viewer and PACS integration, while StrokeViewer Perfusion highlights mobile notifications and Docker deployment flexibility. Given they are from the same company, their underlying usability principles and integration capabilities are likely very similar.

Clinical Value

StrokeViewer Perfusion

StrokeViewer Perfusion offers a more comprehensive and quantitative analysis of CT perfusion scans, providing critical data like core and penumbra volumes, perfusion maps, and collateral assessment. This detailed information is essential for guiding complex treatment decisions, such as thrombectomy eligibility, beyond just initial detection.

Pricing & Value

Tie

Both tools have undisclosed pricing, requiring direct contact with the vendor. Without any public pricing information or details on their value-based pricing models, it is impossible to compare their cost-effectiveness or overall value proposition.

Enterprise Readiness

StrokeViewer Perfusion

Both tools meet essential enterprise requirements with FDA clearance, HIPAA compliance, and BAA. However, StrokeViewer Perfusion offers additional deployment flexibility by being available as a Docker container, which can be installed on standard computers or virtual platforms, catering to a wider range of enterprise IT infrastructures and preferences beyond pure cloud deployment.

Innovation

StrokeViewer Perfusion

While both tools leverage AI innovatively for stroke care, StrokeViewer Perfusion demonstrates a higher degree of innovation through its advanced quantitative CT perfusion analysis. It provides detailed perfusion maps, precise core and penumbra volume quantification, and collateral circulation assessment, pushing the boundaries of AI in complex physiological imaging interpretation.

Support & Docs

Tie

The provided structured facts do not contain any information regarding support or documentation for either tool. Given that both products are from the same company, it is reasonable to assume they share a common support infrastructure and documentation philosophy, making it impossible to distinguish between them on this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	StrokeViewer Perfusion	HALO
Product Name	StrokeViewer Perfusion	HALO
Company	NICo-Lab B.V.	Nico.Lab B.V.
Primary Focus	AI-powered image processing software that analyzes CT perfusion scans to provide quantitative brain tissue information for suspected ischemic stroke patients, aiding in rapid diagnosis and treatment decisions.	AI-powered, cloud-based clinical support tool for the rapid detection of large vessel occlusions and intracerebral hemorrhage in acute stroke patients, providing timely notifications to medical specialists.
Large Vessel Occlusion (LVO) Detection	Large Vessel Occlusion (LVO) detection	AI-powered Large Vessel Occlusion (LVO) detection
Hemorrhage Detection/Quantification	Hemorrhage detection and quantification	Intracerebral Hemorrhage (ICH) detection and volume quantification
CT Perfusion Analysis	AI-powered CT Perfusion analysis, Quantitative perfusion maps (TMax, CBF, CBV), Lesion map for core and penumbra volume quantification	Not specified

Videos

Demos, reviews, and walkthroughs featuring StrokeViewer Perfusion and HALO.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What types of imaging modalities and specific analyses are supported by each tool?

StrokeViewer Perfusion primarily analyzes CT perfusion scans to provide quantitative brain tissue information, including perfusion maps (TMax, CBF, CBV) and lesion maps for core and penumbra volume quantification. HALO focuses on evaluating brain vasculature on CT angiograms for the rapid detection of large vessel occlusions and intracerebral hemorrhage.

What specific quantitative measurements or scores does each tool provide beyond basic detection?

StrokeViewer Perfusion offers quantitative perfusion maps (TMax, CBF, CBV), lesion maps for core and penumbra volume quantification, and ASPECTS scoring. HALO provides volume quantification for intracerebral hemorrhage and facilitates the evaluation of brain vasculature on CT angiograms.

Do both tools offer features for assessing collateral circulation or triaging stroke patients?

StrokeViewer Perfusion includes assessment of collateral circulation as a key feature to aid in treatment decisions. HALO offers a dedicated triage function for stroke patients to prioritize cases based on critical findings.

How do the tools integrate into existing clinical workflows for notification and review?

Both tools provide automated notifications for critical findings to medical specialists to support rapid diagnosis and treatment decisions. HALO additionally supports remote review via a compatible DICOM web viewer and offers DICOM/PACS integration for seamless workflow.